🚨New in EHJ-CVP🚨
HFpEF and HFmrEF therapies continue to evolve rapidly💊
This pre-specified Bayesian analysis of FINEARTS-HF adds another layer to the finerenone story — strengthening the probability of benefit for reducing worsening HF events and CV death across the preserved EF spectrum.
How do you see Bayesian analyses influencing the way we interpret HF trials and future guideline adoption?📊
Read the article in EHJ-CVP:
🔗https://t.co/kaVHrtI8aa
📢New in EHJ-CVP: The journal introduces Rapid Communications📜: a new concise article format for focused clinical & translational research🚀
≤1000 words (excluding references), emphasis on methods/results, 1 figure/table, no abstract or supplementals.
Fast, focused, impactful science!🔬
🔗https://t.co/20aXWom6cO
@BiancaRoccaTwt@doreen_sy@OtiliaTica1@Massimi78530343@Costa_F_8@ESC_Journals@ESCardioNews
📢The new #EHJCVP issue is now online💥the first under Editor-in-Chief Prof. Bianca Rocca & the new editorial board!✍🏼
From innovation in CV pharmacotherapy to research integrity and cutting-edge science across the field🔬the issue opens with an editorial from EiC, setting the tone for journal's direction➡️
🔗https://t.co/LBqzH6LHHp @BiancaRoccaTwt@doreen_sy@Massimi78530343@Costa_F_8@ESCardioNews@ESC_Journals
🆕A new era for #EHJCVP➡️ With this first editorial, we are proud to welcome an international & multidisciplinary Board committed to innovation, diversity, patient-centred care🫀and rigorous science📚
Together, shaping the future of cardiovascular pharmacotherapy🌍💊
🔗https://t.co/nJ3tH2yFhL
Pan & colleagues detected #micro(nano)plastics in human #heart tissue, & higher tissue levels were associated with greater #fibrosis. Learn more about a possible role for plastic particles in adverse cardiac remodeling at https://t.co/cZ0PWeszM4
Meral et al found cell type-resolved #transcriptomics reveal that diastolic dysfunction is linked to a reversible shift in #fibroblast states, driven by #mineralocorticoid receptor signaling. Learn more at https://t.co/vzydjvWSLQ
@MeralDavid
Yoon & colleagues found that the secreted glycoprotein #VEGF-D enhanced endothelial barrier function & conferred protection against #inflammatory in acute #lung injury models. Learn more at https://t.co/zeuA17TanO
@kaminskimed
@CircRes welcomes the submission of Research Letters to accompany a Compendium on Migration of Mitochondria Beyond Cell Boundary: Biology, Physiology, and Therapeutic Potential. Initial submissions are due no later than December 29, 2025. More info here: https://t.co/s2kCs8uddL
#CardiovascularDiabetology@BioMedCentral
Awards Associate Editors of the Year 2025 🎉🏅
Cardiovascular Diabetology is delighted to announce the Associate Editors of the Year 2025:
✨ Prof. @DidacMauricio
✨ Prof. @FrancescoPaneni
This recognition highlights their outstanding dedication, leadership, and invaluable contributions to advancing scientific progress in cardiovascular health and diabetes research 👏👏👏.
https://t.co/MHO8ne62Oj
Two days left to submit an abstract for oral presentation or poster for the New Cardiobiology at EMBL Heidelberg. Don’t miss it. Engineering and Cardiovascular is the future! Deadline extended to Nov 17th!